Clinical Trial Update: A Phase II Study of Clofarabine in Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

This is a Phase II clinical trial evaluating clofarabine in patients with relapsed or refractory multiple myeloma. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Clofarabine (clofarabine)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Multiple Myeloma | Phase 2 | Status: TERMINATED